Rivaroxaban
FW-2020-1380
Unknown small_molecule completed
Quick answer
Rivaroxaban for Ventricular Mural Thrombosis is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Ventricular Mural Thrombosis
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed